相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
Yibo Xue et al.
NATURE COMMUNICATIONS (2019)
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
Yibo Xue et al.
NATURE COMMUNICATIONS (2019)
SMARCA4-deficient Thoracic Sarcomas Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses
Raul Perret et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma
Sarah Chiang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers
Sevtap Savas et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas
Basile Tessier-Cloutier et al.
HISTOPATHOLOGY (2018)
Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
Petar Jelinic et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Antoine Italiano et al.
LANCET ONCOLOGY (2018)
SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma
David L. Kolin et al.
MODERN PATHOLOGY (2018)
A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal
James X. Sun et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
Petar Jelinic et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
N. C. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Recent advances in the histological and molecular classification of endometrial stromal neoplasms
Joana Ferreira et al.
VIRCHOWS ARCHIV (2018)
Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program
Raushan T. Kurmasheva et al.
PEDIATRIC BLOOD & CANCER (2017)
Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type
Douglas I. Lin et al.
GYNECOLOGIC ONCOLOGY (2017)
SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior
Jennifer L. Sauter et al.
MODERN PATHOLOGY (2017)
Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas
Inga-Marie Schaefer et al.
MODERN PATHOLOGY (2017)
Selective Killing of SMARCA2-and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models
Elayne Chan-Penebre et al.
MOLECULAR CANCER THERAPEUTICS (2017)
SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg/CK7pos/HepPar-1pos immunophenotype
Abbas Agaimy et al.
VIRCHOWS ARCHIV (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
Anthony N. Karnezis et al.
JOURNAL OF PATHOLOGY (2016)
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
Jie He et al.
BLOOD (2016)
Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours
Lien N. Hoang et al.
HISTOPATHOLOGY (2016)
A phase 1 study of EPZ-6438 (E7438), an Enhancer of Zeste-Homolog 2 (EZH2) inhibitor: Preliminary activity in INI1-negative tumors
A. Italiano et al.
EUROPEAN JOURNAL OF CANCER (2015)
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
Lifang Zhang et al.
MOLECULAR CANCER (2015)
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
Francois Le Loarer et al.
NATURE GENETICS (2015)
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer
Nicholas C. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature
Diana M. Haninger et al.
MODERN PATHOLOGY (2014)
Familial rhabdoid tumour 'avant la lettre'from pathology review to exome sequencing and back again
Leora Witkowski et al.
JOURNAL OF PATHOLOGY (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Doron Lipson et al.
NATURE MEDICINE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression
Martin Hasselblatt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome
Reinhard Schneppenheim et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type
WG McCluggage et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)